Can somatostatin prevent post-ERCP pancreatitis?
Somatostatin is useful in preventing post-ERCP pancreatitis. Further studies must be designed to investigate the cost-effectiveness of the drug and to determine the ideal administration route and dosage.
Our results suggest a possible therapeutic application of CSYJE for treating inflammatory diseases.